Clinical Trial Update: Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Bucillamine for acute gout flares in patients with moderate to severe gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Bucillamine (bucillamine)

Snippet

Sponsor: Revive Therapeutics, Ltd. | Conditions: Gout | Phase 2 | Status: COMPLETED